OCTOBER, 2012 Gene-Related Patents Issued - Full patent | ||||
CHEMICAL APPARATUS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,278,034 | Methods of making frozen tissue microarrays | Nuclea Biotechnologies, Inc. | 2-Oct-12 | United States |
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,298,776 | Antibodies to tumor associated proteins | Agensys, Inc. | 30-Oct-12 | United States |
8,278,074 | L-glutamic acid-producing microorganism and a method for producing L-glutamic acid | Ajinomoto Co., Inc. | 2-Oct-12 | Japan |
8,278,075 | L-cysteine-producing bacterium and a method for producing L-cysteine | Ajinomoto Co., Inc. | 2-Oct-12 | Japan |
8,293,506 | L-cysteine-producing bacterium and a method for producing L-cysteine | Ajinomoto Co., Inc. | 23-Oct-12 | Japan |
8,298,756 | Isolation, gene expression, and chemotherapeutic resistance of motile cancer cells | Albert Einstein College of Medicine of Yeshiva University | 30-Oct-12 | United States |
8,288,096 | Diagnostic method for epilepsy | Bionomics Limited | 16-Oct-12 | Australia |
8,288,158 | Stem cells modified to facilitate threonine catabolism | Board of Regents, The University of Texas System | 16-Oct-12 | United States |
8,278,066 | Truncated somatostatin receptors | Board of Regents, The University of Texas System | 2-Oct-12 | United States |
8,298,826 | Chimaeric vector system | Cambridge Enterprise Limited | 30-Oct-12 | United Kingdom |
8,288,102 | Gene defects and mutant ALK kinase in human solid tumors | Cell Signaling Technology, Inc. | 16-Oct-12 | United States |
8,298,768 | Efficient shotgun sequencing methods | Complete Genomics, Inc. | 30-Oct-12 | United States |
8,293,529 | Method for inducing differentiation of pluripotent stem cells into cardiomyocytes | Daiichi Sankyo Company, Limited | 23-Oct-12 | Japan |
8,293,499 | Bacillus strain for increased protein production | Danisco US Inc. | 23-Oct-12 | United States |
8,293,514 | Alleles of the rel gene from coryneform bacteria | Evonik Degussa GmbH | 23-Oct-12 | Germany |
8,278,092 | Isolated reductive dehalogenase genes | Georgia Tech Research Corporation | 2-Oct-12 | United States |
8,293,469 | Biomarkers downregulated in prostate cancer | Health Discovery Corporation | 23-Oct-12 | United States |
8,298,819 | Cosmid vector for plant transformation and use thereof | Japan Tobacco Inc. | 30-Oct-12 | Japan |
8,288,099 | Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer | John Wayne Cancer Institute | 16-Oct-12 | United States |
8,283,137 | Process for producing recombinant fibrinogen highly producing cell and highly producing cell | Juridical Foundation the Chemo-Sero-Therapeutic Research Institute | 9-Oct-12 | Japan |
8,288,108 | Expression profiles for predicting septic conditions | Justus-Liebig-Universitat Giessen | 16-Oct-12 | Germany |
8,293,516 | Recombinant microorganism | Kao Corporation | 23-Oct-12 | Japan |
8,298,807 | Micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design | Metabolic Explorer | 30-Oct-12 | France |
8,298,787 | Methods for enhancing a secretion efficiency of recombinant foreign protein in yeast expression system | Mogam Biotechnology Research Institute | 30-Oct-12 | Korea |
8,278,037 | N-acetylgalactosamine transferases and nucleic acids encoding the same | National Institute of Advanced Industrial Science and Technology | 2-Oct-12 | Japan |
8,283,115 | Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation | PTC Therapeutics, Inc. | 9-Oct-12 | United States |
8,283,145 | Chondroitin-producing bacterium and method of producing chondroitin | Seikagaku Corporation | 9-Oct-12 | Japan |
8,288,090 | Influenza vaccines | Statens Serum Institut | 16-Oct-12 | Denmark |
8,288,104 | Methods for predicting the risk of diabetic nephropathy using genetic markers and arrays containing the same | The Chinese University of Hong Kong | 16-Oct-12 | Hong Kong |
8,278,036 | RNA containing modified nucleosides and methods of use thereof | The Trustees of the University of Pennsylvania | 2-Oct-12 | United States |
8,283,122 | Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma | The United States of America, as Represented by the Secretary of the Department of Health and Human Services | 9-Oct-12 | United States |
8,278,107 | Compositions and methods for regulating RNA translation via CD154 CA-dinucleotide repeat | Trustees of Dartmouth College | 2-Oct-12 | United States |
8,278,061 | Polymorphisms in the EGFR pathway as markers for cancer treatment | University of Southern California | 2-Oct-12 | United States |
8,298,789 | Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34) | USV Limited | 30-Oct-12 | India |
8,293,517 | Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in Pseudomonas aeruginosa | Wayne State University | 23-Oct-12 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,301,430 | Systems and methods for constructing genomic-based phenotypic models | Genomatica, Inc. | 30-Oct-12 | United States |
8,301,387 | Combinatorial transcription control for programmed genetic response | The Regents of the University of California | 30-Oct-12 | United States |
8,290,715 | System and method for multiple-factor selection | The Trustees of Columbia University in the City of New York | 16-Oct-12 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,287,883 | Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof | Aduro Biotech, Inc. | 16-Oct-12 | United States |
8,282,924 | Hybrid antibodies | Alexion Pharmaceuticals, Inc. | 9-Oct-12 | United States |
8,299,042 | Methods and compositions for silencing genes without inducing toxicity | Alnylam Pharmaceuticals, Inc. | 30-Oct-12 | United States |
8,282,936 | Human papillomavirus vaccine for oral administration | Asahi Glass Company, Ltd. | 9-Oct-12 | Japan |
8,277,818 | Herpes virus strains for gene therapy | Biovex Limited | 2-Oct-12 | United Kingdom |
8,282,919 | Microorganism strain CRC2631 of Salmonella typhimurium and its use as a cancer therapeutic | Cancer Research Center | 9-Oct-12 | United States |
8,287,863 | Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen | Chugai Seiyaku Kabushiki Kaisha | 16-Oct-12 | Japan |
8,293,244 | Phosphotriesterase from agrobacterium radiobacter p230 | Commonwealth Scientific and Industrial Research Organisation | 23-Oct-12 | Australia |
8,299,044 | Apoptosis inducer for cancer cell | Genecare Research Institute Co., Ltd. | 30-Oct-12 | Japan |
8,298,539 | Human cytomegalovirus neutralizing antibodies and use thereof | Institute for Research in Biomedicine | 30-Oct-12 | Switzerland |
8,287,870 | Human cytomegalovirus neutralizing antibodies and use thereof | Institute for Research in Biomedicine | 16-Oct-12 | Switzerland |
8,278,285 | Gastric carcinoma gene ZNF312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same | Korea Research Institute of Bioscience and Biotechnology | 2-Oct-12 | Korea |
8,287,851 | Use of interleukin 17E for the treatment of cancer | Lorus Therapeutics Inc. | 16-Oct-12 | Canada |
8,287,862 | Multidrug resistance-associated polypeptide | Millennium Pharmaceuticals, Inc. | 16-Oct-12 | United States |
8,282,916 | Tumor therapy with replication competent sindbis viral vectors | New York University | 9-Oct-12 | United States |
8,278,287 | siRNA compounds for inhibiting NRF2 | Quark Pharmaceuticals Inc. | 2-Oct-12 | United States |
8,287,852 | Treatment of viral diseases with recombinant interferon .alpha. | Superlab Far East Limited | 16-Oct-12 | Virgin |
8,277,797 | Interferon-.beta. production modulating Listeria strains and methods for using same | The Regents of the University of California | 2-Oct-12 | United States |
8,282,939 | Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies | Thomas Jefferson University | 9-Oct-12 | United States |
8,298,543 | Identification and application of antibiotic synergy | Trius Therapeutics, Inc. | 30-Oct-12 | United States |
8,287,886 | Tuberculosis vaccine | Universidad de Zaragoza | 16-Oct-12 | Spain |
8,282,918 | Polynucleotides encoding RPA4/RPA32 hybrid polypeptides | University of Iowa Research Foundation | 9-Oct-12 | United States |
8,278,321 | Small molecule inhibition of intracellular transport | Washington University | 2-Oct-12 | United States |
IMAGE ANALYSIS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,280,142 | Predetermined site luminescence measuring method, predetermined site luminescence measuring apparatus, expression amount measuring method, and measuring apparatus | Olympus Corporation | 2-Oct-12 | Japan |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,283,521 | Transcription factor gene induced by water deficit conditions and abscisic acid from Helianthus annuus, promoter and transgenic plants | Bioceres S.A. | 9-Oct-12 | United States |
8,278,505 | Herbicide resistance genes for resistance to aryloxyalkanoate herbicides | Dow AgroSciences, LLC. | 2-Oct-12 | United States |
8,283,522 | Herbicide resistance genes | Dow AgroSciences, LLC. | 9-Oct-12 | United States |
8,293,975 | Method for identifying gene function | Pioneer Hi Bred International Inc | 23-Oct-12 | United States |
8,293,970 | MSCA1 nucleotide sequences impacting plant male fertility and method of using same | Pioneer Hi-Bred International Inc | 23-Oct-12 | United States |
8,293,978 | Marchantiales-derived unsaturated fatty acid synthetase genes and use of the same | Suntory Holdings Limited | 23-Oct-12 | Japan |
8,293,977 | Transgenic plants and methods for controlling bolting in sugar beet | Syngenta Participations AG | 23-Oct-12 | Switzerland |
8,293,974 | Use of double stranded RNA hairpin duplexes in gene silencing | University of Witwatersrand | 23-Oct-12 | South Africa |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,278,424 | Antibodies that bind to PSCA proteins for diagnosis of cancer | Agensys, Inc. | 2-Oct-12 | United States |
8,278,414 | DNA sequence encoding a retinoic acid regulated protein | The Hong Kong University of Science and Technology | 2-Oct-12 | Hong Kong |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,288,525 | Compositions and methods for inhibiting expression of CD45 gene | Alnylam Pharmaceuticals, Inc. | 16-Oct-12 | United States |
8,283,462 | Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof | Beijing Solobio Genetechnology Company Ltd. | 9-Oct-12 | China P. Rep. |
8,299,233 | Molecular in vitro diagnosis of breast cancer | Centre National de la Recherche Scientifique | 30-Oct-12 | France |
8,299,232 | Constructing a DNA chimera for vaccine development against leishmaniasis and tuberculosis | Department of Biotechnology | 30-Oct-12 | India |
8,293,887 | SiRNA targeting beta secretase (BACE) | Dharmacon, Inc. | 23-Oct-12 | United States |
8,278,431 | Polynucleotides and polypeptides involved in post-transcriptional gene silencing | E.I. du Pont de Nemours and Company | 2-Oct-12 | United States |
8,293,885 | Assay and compositions for detection of Bacillus anthracis nucleic acid | Gen-Probe Incorporated | 23-Oct-12 | United States |
8,299,234 | siRNA hat inhibits WT1 gene expression and uses thereof | Haruo Sugiyama | 30-Oct-12 | Japan |
8,299,236 | Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells | Marina Biotech, Inc. | 30-Oct-12 | United States |
8,299,235 | RNA molecules and vectors for gene silencing | Plant Bioscience Limited | 30-Oct-12 | United Kingdom |
8,283,460 | Short hairpin RNAs for inhibition of gene expression | Somagenics, Inc. | 9-Oct-12 | United States |
8,283,329 | Genetic inhibition of double-stranded RNA | The Carnegie Institution of Washington | 9-Oct-12 | United States |
8,299,238 | Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals | University of Saskatchewan | 30-Oct-12 | Canada |
8,293,880 | Prognostic panel for urinary bladder cancer | University of Southern California | 23-Oct-12 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.